Updated version of this database is available at ThpDB2

Browse result page of THPdb

The total number entries retrieved from this search are 48
ID1055ThPPIDTh1009NameAlteplasePeptide SequenceSYQVICRDEKTQMIYQQHQS Full viewLength255Functional ClassificationIbDiseaseHematological,MetabolicBrandActivaseCompanyGenentech IncPhysical AppearanceSterile, white to off-white, lyophilized powderRoute of AdministartionIntravenousCategoryThrombolytic Agents TargetPlasminogen,Fibrinogen alpha chain,Urokinase plasminogen activator surface receptor,Plasminogen activator inhibitor 1
ID1067ThPPIDTh1012NameReteplasePeptide SequenceSYQGNSDCYFGNGSAYRGTH Full viewLength255Functional ClassificationIbDiseaseHematological,MetabolicBrandRetavaseCompanyCentocorPhysical AppearanceSterile, white, lyophilized powderRoute of AdministartionIntravenous InjectionCategoryFibrinolytic Agents, Thrombolytic agents TargetPlasminogen,Fibrinogen alpha chain,Urokinase plasminogen activator surface receptor,Plasminogen activator inhibitor 1
ID1117ThPPIDTh1016NamePegfilgrastimPeptide SequenceMTPLGPASSLPQSFLLKCLE Full viewLength175Functional ClassificationIbDiseaseImmunologicalBrandNeulastaCompanyAmgen Inc.Physical AppearanceSolutionRoute of AdministartionSubcutaneous injectionCategoryImmunosuppressive Agents, Anti-neutropenic agents TargetGranulocyte colony-stimulating factor receptor,Neutrophil elastase
ID1148ThPPIDTh1022NameAntihemophilic FactorPeptide SequenceATRRYYLGAVELSWDYMQSD Full viewLength255Functional ClassificationIaDiseaseHematological,MetabolicBrandAdvateCompanyN.A.Physical AppearancePowder formRoute of AdministartionIntravenous InjectionCategoryCoagulants and Thrombotic agents TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1149ThPPIDTh1022NameAntihemophilic FactorPeptide SequenceATRRYYLGAVELSWDYMQSD Full viewLength255Functional ClassificationIaDiseaseHematological,MetabolicBrandAlphanateCompanyN.A.Physical AppearanceLyophilized powderRoute of AdministartionIntravenous InjectionCategoryCoagulants and Thrombotic agents TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1150ThPPIDTh1022NameAntihemophilic FactorPeptide SequenceATRRYYLGAVELSWDYMQSD Full viewLength255Functional ClassificationIaDiseaseHematological,MetabolicBrandBioclateCompanyBaxter Healthcare Corporation, Hyland Division and Genetics Institute, Inc.Physical AppearanceSterile, nonpyrogenic, off-white to faint yellow, lyophilized powderRoute of AdministartionIntravenous infusionCategoryCoagulants and Thrombotic agents TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1151ThPPIDTh1022NameAntihemophilic FactorPeptide SequenceATRRYYLGAVELSWDYMQSD Full viewLength255Functional ClassificationIaDiseaseHematological,MetabolicBrandHelixate FSCompanyN.A.Physical AppearanceSterile, stable, purified, nonpyrogenic, dried concentrateRoute of AdministartionIntravenous InjectionCategoryCoagulants and Thrombotic agents TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1152ThPPIDTh1022NameAntihemophilic FactorPeptide SequenceATRRYYLGAVELSWDYMQSD Full viewLength255Functional ClassificationIaDiseaseHematological,MetabolicBrandHemofil MCompanyN.A.Physical AppearanceDry concentrateRoute of AdministartionIntravenous InjectionCategoryCoagulants and Thrombotic agents TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1153ThPPIDTh1022NameAntihemophilic FactorPeptide SequenceATRRYYLGAVELSWDYMQSD Full viewLength255Functional ClassificationIaDiseaseHematological,MetabolicBrandHyate:CCompanyN.A.Physical AppearancePowderRoute of AdministartionIntravenous InjectionCategoryCoagulants and Thrombotic agents TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1154ThPPIDTh1022NameAntihemophilic FactorPeptide SequenceATRRYYLGAVELSWDYMQSD Full viewLength255Functional ClassificationIaDiseaseHematological,MetabolicBrandKoate-HPCompanyN.A.Physical AppearancePowderRoute of AdministartionIntravenous InjectionCategoryCoagulants and Thrombotic agents TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1155ThPPIDTh1022NameAntihemophilic FactorPeptide SequenceATRRYYLGAVELSWDYMQSD Full viewLength255Functional ClassificationIaDiseaseHematological,MetabolicBrandKogenate FSCompanyN.A.Physical AppearancePowderRoute of AdministartionIntravenous InjectionCategoryCoagulants and Thrombotic agents TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1156ThPPIDTh1022NameAntihemophilic FactorPeptide SequenceATRRYYLGAVELSWDYMQSD Full viewLength255Functional ClassificationIaDiseaseHematological,MetabolicBrandMonarc-MCompanyN.A.Physical AppearancePowderRoute of AdministartionIntravenous InjectionCategoryCoagulants and Thrombotic agents TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1157ThPPIDTh1022NameAntihemophilic FactorPeptide SequenceATRRYYLGAVELSWDYMQSD Full viewLength255Functional ClassificationIaDiseaseHematological,MetabolicBrandMonoclate-PCompanyN.A.Physical AppearanceLyophilized powder for solutionRoute of AdministartionIntravenous InjectionCategoryCoagulants and Thrombotic agents TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1158ThPPIDTh1022NameAntihemophilic FactorPeptide SequenceATRRYYLGAVELSWDYMQSD Full viewLength255Functional ClassificationIaDiseaseHematological,MetabolicBrandReFactoCompanyN.A.Physical AppearanceLyophilized powderRoute of AdministartionIntravenous InjectionCategoryCoagulants and Thrombotic agents TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1159ThPPIDTh1022NameAntihemophilic FactorPeptide SequenceATRRYYLGAVELSWDYMQSD Full viewLength255Functional ClassificationIaDiseaseHematological,MetabolicBrandXynthaCompanyN.A.Physical AppearanceSterile, nonpyrogenic, preservative-free, freeze-dried powderRoute of AdministartionIntravenous InjectionCategoryCoagulants and Thrombotic agents TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1201ThPPIDTh1026NameAnistreplasePeptide SequenceSYQVICRDEKTQMIYQQHQS Full viewLength255Functional ClassificationIcDiseaseHematological,MetabolicBrandEminaseCompanyWulfing Pharma GmbHPhysical AppearanceDry powderRoute of AdministartionIntravenous infusionCategoryThrombolytic Agents, Fibrinolytic agents TargetPlasminogen,Fibrinogen alpha chain,Urokinase plasminogen activator surface receptor,Plasminogen activator inhibitor 1
ID1205ThPPIDTh1027NameInsulin RegularPeptide SequenceA-chain:GIVEQCCTSIC< Full viewLength51Functional ClassificationIaDiseaseGenetic/HormonalBrandHumulin RCompanyEli Lilly and CompanyPhysical AppearanceSterile, clear, aqueous, and colorless solutionRoute of AdministartionSubcutaneous injection in the abdominal wall, the thigh, the gluteal region or in the upper arm and Intravenousadministration of Humulin R (insulin (human recombinant)) U-100 is possible under medical supervision.CategoryAntidiabetic Agents TargetInsulin receptor,Insulin-like growth factor 1 receptor,Retinoblastoma-associated protein,Cathepsin D,Insulin-degrading enzyme,Neuroendocrine convertase 2,Carboxypeptidase E,Neuroendocrine convertase 1,Protein NOV homolog,Low-density lipoprotein receptor-r
ID1206ThPPIDTh1027NameInsulin RegularPeptide SequenceA-chain:GIVEQCCTSIC< Full viewLength51Functional ClassificationIaDiseaseGenetic/HormonalBrandNovolin RCompanyNovo NordiskPhysical AppearanceSterile, clear, aqueous, and colorless solutionRoute of AdministartionSubcutaneous and Intravenous infusionCategoryAntidiabetic Agents TargetInsulin receptor,Insulin-like growth factor 1 receptor,Retinoblastoma-associated protein,Cathepsin D,Insulin-degrading enzyme,Neuroendocrine convertase 2,Carboxypeptidase E,Neuroendocrine convertase 1,Protein NOV homolog,Low-density lipoprotein receptor-r
ID1210ThPPIDTh1028NameTenecteplasePeptide SequenceSYQVICRDEKTQMIYQQHQS Full viewLength255Functional ClassificationIbDiseaseHematological,MetabolicBrandTNKaseCompanyGenentech IncPhysical AppearanceSterile, white to off-white, lyophilized powderRoute of AdministartionIntravenous InjectionCategoryThrombolytic Agents, Fibrinolytic agents TargetPlasminogen,Fibrinogen alpha chain,Urokinase plasminogen activator surface receptor,Plasminogen activator inhibitor 1,Plasminogen activator inhibitor 2,Tetranectin,Keratin, type II cytoskeletal 8,Annexin A2,Calreticulin,Calnexin,Prolow-density lipoprotein
ID1234ThPPIDTh1032NameCoagulation factor VIIaPeptide SequenceANAFLEELRPGSLERECKEE Full viewLength255Functional ClassificationIbDiseaseHematological,MetabolicBrandNovoSevenCompanyNovo NordiskPhysical AppearanceSterile, white lyophilized powderRoute of AdministartionInjectionCategoryThrombotic Agents, Coagulants TargetCoagulation factor X,Serine protease hepsin,Tissue factor pathway inhibitor,Vitamin K-dependent gamma-carboxylase,Coagulation factor VII,Tissue factor
ID1246ThPPIDTh1034NamePaliferminPeptide SequenceSYDYMEGGDIRVRRLFCRTQ Full viewLength140Functional ClassificationIbDiseaseCancerBrandKepivanceCompanyAmgen IncPhysical AppearanceSterile, lyophilized powderRoute of AdministartionIntravenous infusionCategoryAnti-Mucositis Agents TargetFibroblast growth factor receptor 2,Neuropilin-1,Fibroblast growth factor receptor 1,Fibroblast growth factor receptor 4,Fibroblast growth factor receptor 3,Basement membrane-specific heparan sulfate proteoglycan core protein
ID1331ThPPIDTh1047NameAlpha-1-proteinase inhibitorPeptide SequenceEDPQGDAAQKTDTSHHDQDH Full viewLength255Functional ClassificationIIaDiseaseMetabolic/Geneti/RespiratoryBrandAralastCompanyBaxterPhysical AppearanceLyophilized powderRoute of AdministartionIntravenous infusionCategorySerine Proteinase Inhibitors, Enzyme replacement agents, trypsin inhibitors TargetNeutrophil elastase
ID1332ThPPIDTh1047NameAlpha-1-proteinase inhibitorPeptide SequenceEDPQGDAAQKTDTSHHDQDH Full viewLength255Functional ClassificationIIaDiseaseMetabolic/Geneti/RespiratoryBrandProlastinCompanyTalecris Biotherapeutics C formerly BayerPhysical AppearanceLyophilized powderRoute of AdministartionIntravenous infusionCategorySerine Proteinase Inhibitors, Enzyme replacement agents, trypsin inhibitors TargetNeutrophil elastase
ID1385ThPPIDTh1061NameTrastuzumabPeptide SequenceLight chain 1: DIQMT Full viewLength1364Functional ClassificationIIaDiseaseCancerBrandHerceptinCompanyGenentechPhysical AppearanceSterile, white to pale yellow, preservative-free lyophilized powderRoute of Administartion Intravenous administrationCategoryAntineoplastic Agents TargetInsulin receptor,Insulin-like growth factor 1 receptor,Insulin-degrading enzyme,HLA class II histocompatibility antigen, DQ alpha 2 chain,HLA class II histocompatibility antigen, DQ beta 1 chain,Retinoblastoma-associated protein,Cathepsin D,Carboxypeptidase E,Neuroendocrine convertase 2,Neuroendocrine convertase 1,Protein NOV homolog,Low-density lipoprotein receptor-related protein 2,Insulin-like growth factor-binding protein 7,Synaptotagmin-like protein 4
ID1389ThPPIDTh1062NameRituximabPeptide SequenceHeavy Chain: QVQLQQP Full viewLength664Functional ClassificationIIaDiseaseCancer/ImmunologicalBrandRituxanCompanyBiogen Idec Inc., and Genentech USA, IncPhysical AppearanceSterile, clear, colorless, preservative-free liquid concentrateRoute of Administartion Intravenous administrationCategoryAntineoplastic Agents, Immunologic Factors and Antirheumatic Agents TargetB-lymphocyte antigen CD20,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c, Receptor tyrosine-protein kinase erbB-2,Epidermal growth factor receptor,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor I
ID1434ThPPIDTh1074NameAlglucerasePeptide SequenceARPCIPKSFGYSSVVCVCNA Full viewLength497Functional ClassificationIaDiseaseMetabolicBrandCeredaseCompanyGenzyme CorporationPhysical AppearanceClear sterile non-pyrogenic solution of alglucerase in a citrate buffered solutionRoute of AdministartionIntravenous injectionCategoryEnzyme Replacement Agents TargetPlasminogen,Proteinase-activated receptor 1
ID1439ThPPIDTh1077NameUrofollitropinPeptide SequenceAlpha chain:APDVQDCP Full viewLength203Functional ClassificationIbDiseaseHormonalBrandBRAVELLECompanyFerring Pharmaceuticals Inc.Physical AppearanceSterile, lyophilized powder used after reconstitution with sterile 0.9% Sodium Chloride InjectionRoute of AdministartionIntramuscular and Subcutaneous administration CategoryFertility Agents TargetGlutamate carboxypeptidase 2
ID1440ThPPIDTh1077NameUrofollitropinPeptide SequenceAlpha chain:APDVQDCP Full viewLength203Functional ClassificationIbDiseaseHormonalBrandMetrodinCompanyN.A.Physical AppearanceSterile, lypholized form contains an acidic, water soluble glycoprotein biologically standardized for FSH gonadotropin activityRoute of AdministartionIntramuscular injection.CategoryFertility Agents TargetGlutamate carboxypeptidase 2
ID1441ThPPIDTh1077NameUrofollitropinPeptide SequenceAlpha chain:APDVQDCP Full viewLength203Functional ClassificationIbDiseaseHormonalBrandFertinexCompanyN.A.Physical AppearanceSterile, lyophilized form contains an acidic, water soluble glycoprotein biologically standardized for FSH gonadotropin activityRoute of AdministartionSubcutaneous injection.CategoryFertility Agents TargetGlutamate carboxypeptidase 2
ID1456ThPPIDTh1086NameInterferon Alfa-2B, RecombinantPeptide SequenceCDLPQTHSLGSRRTLMLLAQ Full viewLength165Functional ClassificationIbDiseaseImmunologicalBrandINTRON® ACompanyMerckPhysical AppearancePowder or solutionRoute of AdministartionIntramuscular, Subcutaneous, Intralesional, or Intravenous injectionCategoryImmunosuppressive Agents TargetGranulocyte colony-stimulating factor receptor,Neutrophil elastase, Coagulation factor X,Coagulation factor XI,Coagulation factor VII,Coagulation factor VIII,Prothrombin,Prolow-density lipoprotein receptor-related protein 1,Vitamin K-dependent gamma-carboxylase, Platelet-derived growth factor receptor beta,Platelet-derived growth factor receptor alpha,Alpha-2-macroglobulin
ID1560ThPPIDTh1121NamePertuzumabPeptide Sequencelight chain DIQMTQSP Full viewLength664Functional ClassificationIIIcDiseaseCancerBrandPerjetaCompanyGenentechPhysical AppearanceSterile, clear to slightly opalescent, colorless to pale brown liquidRoute of AdministartionIntravenous infusionCategoryMonoclonal antibodies TargetReceptor tyrosine-protein kinase erbB-2
ID1602ThPPIDTh1128NameVelaglucerase AlfaPeptide SequenceARPCIPKSFGYSSVVCVCNA Full viewLength497Functional ClassificationIaDiseaseHormonalBrandVPRIVCompanyShirePhysical AppearanceSterile, preservative free, lyophilized powderRoute of AdministartionIntravenous infusionCategoryEnzymes TargetGlucosylceramidase
ID1659ThPPIDTh1152NameDrotrecogin alfaPeptide SequenceHeavy Chain: LIDGKMT Full viewLength402Functional ClassificationIbDiseaseInfectiousBrandXigrisCompanyEli Lilly and CompanyPhysical AppearanceSterile, lyophilized, white to off-white powderRoute of AdministartionIntravenous InfusionCategoryAntisepsis TargetCoagulation factor VIII, V, Plasminogen activator inhibitor 1, Thrombomodulin, Vitamin K-dependent protein S, Ceruloplasmin, Prothrombin, Platelet factor 4, Plasma serine protease inhibitor, Serpin B6, Vitamin K-dependent gamma-carboxylase, Endothelial protein C receptor
ID1663ThPPIDTh1155NameUrokinasePeptide SequenceKPSSPPEELKFQCGQKTLRP Full viewLength276Functional ClassificationIbDiseaseHaemetologicalBrandKinlyticCompanyN.A.Physical AppearanceSterile lyophilized white powderRoute of AdministartionIntravenous infusionCategoryN.A. TargetPlasminogen,Urokinase plasminogen activator surface receptor, Urokinase-type plasminogen activator, Tissue-type plasminogen activator, Plasminogen activator inhibitor 1, 2, Plasma serine protease inhibitor, Low-density lipoprotein receptor-related protein 2, Suppressor of tumorigenicity 14 protein, Nidogen-1
ID1678ThPPIDTh1162NameAlirocumabPeptide SequenceNA Full viewLength0Functional ClassificationIcDiseaseMetabolic/CardiacBrandPraluentCompanySanofi Aventis U.S. LlcPhysical AppearanceInjection, SolutionRoute of AdministartionSubcutaneousCategoryN.A. TargetProprotein convertase subtilisin/kexin type 9
ID1679ThPPIDTh1162NameAlirocumabPeptide SequenceNA Full viewLength0Functional ClassificationIcDiseaseMetabolic/CardiacBrandPraluentCompanySanofi Aventis Canada IncPhysical AppearanceSolutionRoute of AdministartionSubcutaneousCategoryN.A. TargetProprotein convertase subtilisin/kexin type 10
ID1680ThPPIDTh1162NameAlirocumabPeptide SequenceNA Full viewLength0Functional ClassificationIcDiseaseMetabolic/CardiacBrandPraluentCompanySanofi Aventis Canada IncPhysical AppearanceSolutionRoute of AdministartionSubcutaneousCategoryN.A. TargetProprotein convertase subtilisin/kexin type 11
ID1681ThPPIDTh1162NameAlirocumabPeptide SequenceNA Full viewLength0Functional ClassificationIcDiseaseMetabolic/CardiacBrandPraluentCompanySanofi Aventis U.S. LlcPhysical AppearanceInjection, SolutionRoute of AdministartionSubcutaneousCategoryN.A. TargetProprotein convertase subtilisin/kexin type 14
ID1715ThPPIDTh1171NameC1 Esterase Inhibitor (Human)Peptide SequenceNA Full viewLength0Functional ClassificationIaDiseaseGenetic DisordersBrandBerinert 1500CompanyCsl Behring Canada IncPhysical Appearancekit; Powder for SolutionRoute of AdministartionIntravenousCategoryNA TargetPlasma protease C1 inhibitor
ID1717ThPPIDTh1171NameC1 Esterase Inhibitor (Human)Peptide SequenceNA Full viewLength0Functional ClassificationIaDiseaseGenetic DisordersBrandCinryzeCompanyViropharma Biologics IncPhysical AppearancePowder for SolutionRoute of AdministartionIntravenousCategoryNA TargetPlasma protease C1 inhibitor
ID1724ThPPIDTh1174NameDaratumumabPeptide SequenceNA Full viewLength0Functional ClassificationIIIcDiseaseCancerBrandDarzalexCompanyJanssen Biotech, Inc.Physical AppearanceSolution, concentrateRoute of AdministartionIntravenousCategoryAntineoplastic Agents TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1
ID1736ThPPIDTh1177NameElosulfase alfaPeptide SequenceAPQPPNILLLLMDDMGWGDL Full viewLength496Functional ClassificationIaDiseaseMetabolic DisordersBrandVimizimCompanyBiomarin International LimitedPhysical AppearanceSolutionRoute of AdministartionIntravenousCategoryEnzymes; Alimentary Tract and Metabolism TargetN-acetylgalactosamine-6-sulfatase
ID1741ThPPIDTh1179NameEvolocumabPeptide SequenceNA Full viewLength0Functional ClassificationIIaDiseaseGenetic/Metabolic/CardiacBrandNACompanyNAPhysical AppearanceInjection, Solution; InjectionRoute of AdministartionSubcutaneousCategoryLipid Modifying Agents, Plain; Cardiovascular System TargetProprotein convertase subtilisin/kexin type 9
ID1742ThPPIDTh1179NameEvolocumabPeptide SequenceNA Full viewLength0Functional ClassificationIIaDiseaseGenetic/Metabolic/CardiacBrandRepathaCompanyAmgen IncPhysical AppearanceInjection, SolutionRoute of AdministartionSubcutaneousCategoryLipid Modifying Agents, Plain; Cardiovascular System TargetProprotein convertase subtilisin/kexin type 10
ID1743ThPPIDTh1179NameEvolocumabPeptide SequenceNA Full viewLength0Functional ClassificationIIaDiseaseGenetic/Metabolic/CardiacBrandRepathaCompanyAmgen Canada IncPhysical AppearanceSolutionRoute of AdministartionSubcutaneousCategoryLipid Modifying Agents, Plain; Cardiovascular System TargetProprotein convertase subtilisin/kexin type 11
ID1744ThPPIDTh1179NameEvolocumabPeptide SequenceNA Full viewLength0Functional ClassificationIIaDiseaseGenetic/Metabolic/CardiacBrandRepathaCompanyAmgen IncPhysical AppearanceInjection, SolutionRoute of AdministartionSubcutaneousCategoryLipid Modifying Agents, Plain; Cardiovascular System TargetProprotein convertase subtilisin/kexin type 12
ID1821ThPPIDTh1212NameInsulin PorkPeptide SequenceA chain GIVEQCCTSICS Full viewLength68Functional ClassificationIaDiseaseMetabolic DisordersBrandIletin IICompanyLillyPhysical Appearancesterile suspensionRoute of AdministartionSubcutaneousCategoryHypoglycemic Agents, Antidiabetic Agents TargetInsulin receptor, Insulin-like growth factor 1 receptor, Insulin-degrading enzyme, HLA class II histocompatibility antigen, DQ alpha 2 chain, HLA class II histocompatibility antigen, DQ beta 1 chain, Retinoblastoma-associated protein, Cathepsin D, Carboxypeptidase E, Neuroendocrine convertase 2, Neuroendocrine convertase 1, Protein NOV homolog, Low-density lipoprotein receptor-related protein 2, Insulin-like growth factor-binding protein 7, Synaptotagmin-like protein 4, Cytochrome P450 1A2
ID1848ThPPIDTh1236NameSipuleucel-TPeptide SequenceNA Full viewLength0Functional ClassificationIIIcDiseaseCancerBrandProvengeCompanyNAPhysical AppearanceSolutionRoute of AdministartionIntravenousCategoryAntineoplastic and Immunomodulating Agents TargetProstatic acid phosphatase